Investigating how FGF21 affects metabolic syndrome after undernutrition refeeding
Official title: FGF21 protects from progressive metabolic syndrome after undernutrition refeeding
Funded at University of Texas Med Br Galveston · NIH-10786998 · Data updated 2026-11-12
This study is looking at how not getting enough nutrition as a child can lead to weight and health problems later in life, especially after eating normally again, and it’s using mice to see how a missing protein affects their eating habits and metabolism.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $132,116 |
| NIH project number | 1K01HL171461-01 |
| Project ID | NIH-10786998 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals over 21 years old who have a history of undernutrition or related metabolic issues.
✕Less likely to help
Patients who have not experienced undernutrition or do not have metabolic syndrome may not benefit from this research.
What this research studies
This research explores the impact of undernutrition during childhood on the development of metabolic syndrome (MetS) later in life, particularly after refeeding. It aims to understand how the loss of a protein called FGF21 may contribute to obesity, insulin resistance, and other metabolic issues. By using mouse models, the study will compare the effects of refeeding on normal mice and those lacking FGF21, focusing on behaviors like food preference and overeating. The findings could provide insights into the biological mechanisms behind MetS and potential interventions.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating metabolic syndrome in individuals who have experienced undernutrition.
How similar studies have gone: Previous research has indicated that understanding the role of proteins like FGF21 in metabolic processes can lead to significant advancements in treating metabolic disorders.
Where this research is happening
-
University of Texas Med Br Galveston
Galveston, United States Active
Researchers
- Principal investigator: Osorio, Elvia Janeth — University of Texas Med Br Galveston
- Study coordinator: Osorio, Elvia Janeth
Related research
Other NIH-funded projects on the same topics.
-
Integrated biomarker study of metabolic syndrome in pregnant women with HIV on DTG-based ART
Researchers will look for biological signs in pregnant women with HIV on a DTG-based regimen to understand why weight gain and metabolic problems happen and how these affect pregnancy.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based ART
This project looks at why some pregnant women living with HIV on a common DTG-based therapy gain weight or develop metabolic problems, by studying their proteins and metabolites across four sites in the US and Nigeria.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based therapy
This project looks at markers in pregnant women living with HIV who are on a DTG-containing regimen to understand why some develop metabolic problems during pregnancy.
-
Metabolic syndrome and brain support cells: how it may lead to Alzheimer’s disease
A researcher is studying how midlife metabolic problems like diabetes and obesity may disrupt brain cells that support neurons, potentially leading to Alzheimer's disease and related dementia in later life.
-
GLP-1 medicines to improve heart, kidney, and metabolic health for people with HIV and type 2 diabetes
A real-world study will look at how GLP-1 receptor agonists affect heart and kidney health and lifetime costs for people living with HIV and type 2 diabetes.
-
A new metabolic risk score to predict heart disease in Yup’ik Alaska Native adults
A new, questions-free way to measure heart-disease risk in Yup’ik Alaska Native adults by combining everyday health clues with home-life factors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.